• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Why do we need regional chronic kidney disease-mineral bone disorders guidelines?我们为什么需要地区性慢性肾脏病-矿物质和骨异常指南？
Kidney Res Clin Pract. 2018 Jun;37(2):101-102. doi: 10.23876/j.krcp.2018.37.2.101. Epub 2018 Jun 30.
2
Clinical practice guidelines for the prevention, diagnosis, evaluation and treatment of mineral and bone disorders in chronic kidney disease (CKD-MBD) in adults.成人慢性肾脏病（CKD）矿物质和骨异常（CKD-MBD）预防、诊断、评估及治疗的临床实践指南。
Nefrologia. 2013;33 Suppl 1:1-28. doi: 10.3265/Nefrologia.pre2013.Feb.11945.
3
Optimal management of bone mineral disorders in chronic kidney disease and end stage renal disease.慢性肾脏病及终末期肾病中骨矿物质紊乱的优化管理
Curr Opin Nephrol Hypertens. 2016 Mar;25(2):120-6. doi: 10.1097/MNH.0000000000000203.
4
[Complications and treatment of mineral and bone disorders in chronic kidney disease].[慢性肾脏病矿物质和骨异常的并发症与治疗]
Nephrol Ther. 2019 Jul;15(4):242-258. doi: 10.1016/j.nephro.2019.05.001. Epub 2019 May 25.
5
Improving global outcomes in mineral and bone disorders.改善矿物质与骨疾病的全球治疗效果。
Clin J Am Soc Nephrol. 2008 Nov;3 Suppl 3(Suppl 3):S127-30. doi: 10.2215/CJN.04331206.
6
[Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].3、4、5期慢性肾脏病（未透析）患者矿物质代谢的变化
Nefrologia. 2008;28 Suppl 3:67-78.
7
[Guideline for the management of chronic kidney disease-related mineral and bone disorders (CKD-MBD)].
Clin Calcium. 2007 May;17(5):752-9.
8
Battleground: chronic kidney disorders mineral and bone disease--calcium obsession, vitamin d, and binder confusion.战场：慢性肾脏病矿物质和骨病——对钙的过度关注、维生素D及结合剂的困惑
Clin J Am Soc Nephrol. 2008 Jan;3(1):168-73. doi: 10.2215/CJN.03850907. Epub 2007 Nov 28.
9
[Disorders of bone and mineral metabolism in CKD: CKD-MBD as a new entity].[慢性肾脏病中的骨与矿物质代谢紊乱：作为一种新实体的慢性肾脏病-矿物质和骨异常]
Clin Calcium. 2007 May;17(5):660-4.
10
Bone health in chronic kidney disease-mineral and bone disorder: a clinical case seminar and update.慢性肾脏病-矿物质和骨异常中的骨骼健康：临床病例研讨会及最新进展
Intern Med J. 2018 Dec;48(12):1435-1446. doi: 10.1111/imj.14129.

本文引用的文献

1
Stabilization of serum alkaline phosphatase in hemodialysis patients by implementation of local chronic kidney disease-mineral bone disorder management strategy: A quality improvement study.通过实施局部慢性肾脏病-矿物质和骨异常管理策略稳定血液透析患者血清碱性磷酸酶水平：一项质量改进研究。
Kidney Res Clin Pract. 2018 Jun;37(2):157-166. doi: 10.23876/j.krcp.2018.37.2.157. Epub 2018 Jun 30.
2
Serum calcium and phosphorus levels in patients undergoing maintenance hemodialysis: A multicentre study in Korea.接受维持性血液透析患者的血清钙磷水平：韩国的一项多中心研究。
Kidney Res Clin Pract. 2014 Mar;33(1):52-7. doi: 10.1016/j.krcp.2013.12.003. Epub 2014 Feb 21.
3
Management of chronic kidney disease-mineral and bone disorder: Korean working group recommendations.慢性肾脏病 - 矿物质和骨异常的管理：韩国工作组建议
Kidney Res Clin Pract. 2015 Mar;34(1):4-12. doi: 10.1016/j.krcp.2015.02.002. Epub 2015 Feb 24.
4
Gaps between Global Guidelines and Local Practices in CKD-MBD.慢性肾脏病-矿物质和骨异常全球指南与地方实践之间的差距
Electrolyte Blood Press. 2014 Dec;12(2):35-40. doi: 10.5049/EBP.2014.12.2.35. Epub 2014 Dec 31.
5
Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder.慢性肾脏病-矿物质和骨异常管理的临床实践指南
Ther Apher Dial. 2013 Jun;17(3):247-88. doi: 10.1111/1744-9987.12058.
6
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).改善全球肾脏病预后组织（KDIGO）慢性肾脏病-矿物质和骨异常（CKD-MBD）诊断、评估、预防及治疗临床实践指南。
Kidney Int Suppl. 2009 Aug(113):S1-130. doi: 10.1038/ki.2009.188.
7
Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients.慢性透析患者继发性甲状旁腺功能亢进管理的临床实践指南
Ther Apher Dial. 2008 Dec;12(6):514-25. doi: 10.1111/j.1744-9987.2008.00648.x.
8
Impact of cinacalcet hydrochloride on the achievement of the Japanese Society for Dialysis Therapy (JSDT) guideline targets: a post-hoc analysis of the KRN1493 study.盐酸西那卡塞对日本透析治疗学会（JSDT）指南目标达成情况的影响：KRN1493研究的事后分析
Ther Apher Dial. 2008 Oct;12 Suppl 1:S44-9. doi: 10.1111/j.1744-9987.2008.00631.x.
9
Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study.血液透析患者的钙、磷、甲状旁腺激素与心血管疾病：美国肾脏数据系统第1、3和4波研究
J Am Soc Nephrol. 2005 Jun;16(6):1788-93. doi: 10.1681/ASN.2004040275. Epub 2005 Apr 6.
10
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.慢性肾脏病骨代谢与疾病的K/DOQI临床实践指南
Am J Kidney Dis. 2003 Oct;42(4 Suppl 3):S1-201.

Why do we need regional chronic kidney disease-mineral bone disorders guidelines?

作者信息

Oh Hyung Jung, Ryu Dong-Ryeol

机构信息

Ewha Institute of Convergence Medicine, Ewha Womans University Mokdong Hospital, Seoul, Korea.

Research Institute for Human Health Information, Ewha Womans University Mokdong Hospital, Seoul, Korea.

出版信息

Kidney Res Clin Pract. 2018 Jun;37(2):101-102. doi: 10.23876/j.krcp.2018.37.2.101. Epub 2018 Jun 30.

DOI:10.23876/j.krcp.2018.37.2.101
PMID:29971203
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6027814/
Abstract
摘要